Wells Fargo’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $226M | Buy |
|
|||||
2025
Q1 | $230M | Sell |
|
|||||
2024
Q4 | $210M | Sell |
|
|||||
2024
Q3 | $263M | Sell |
|
|||||
2024
Q2 | $288M | Buy |
|
|||||
2024
Q1 | $210M | Buy |
|
|||||
2023
Q4 | $205M | Buy |
|
|||||
2023
Q3 | $192M | Buy |
|
|||||
2023
Q2 | $196M | Sell |
|
|||||
2023
Q1 | $191M | Buy |
|
|||||
2022
Q4 | $155M | Sell |
|
|||||
2022
Q3 | $131M | Buy |
|
|||||
2022
Q2 | $156M | Buy |
|
|||||
2022
Q1 | $152M | Buy |
|
|||||
2021
Q4 | $90.7M | Buy |
|
|||||
2021
Q3 | $92.4M | Buy |
|
|||||
2021
Q2 | $82.9M | Sell |
|
|||||
2021
Q1 | $82M | Sell |
|
|||||
2020
Q4 | $95.7M | Sell |
|
|||||
2020
Q3 | $132M | Buy |
|
|||||
2020
Q2 | $118M | Buy |
|
|||||
2020
Q1 | $94.4M | Sell |
|
|||||
2019
Q4 | $109M | Sell |
|
|||||
2019
Q3 | $97.4M | Buy |
|
|||||
2019
Q2 | $85.3M | Sell |
|
|||||
2019
Q1 | $101M | Sell |
|
|||||
2018
Q4 | $115M | Sell |
|
|||||
2018
Q3 | $131M | Sell |
|
|||||
2018
Q2 | $133M | Sell |
|
|||||
2018
Q1 | $136M | Sell |
|
|||||
2017
Q4 | $149M | Sell |
|
|||||
2017
Q3 | $149M | Buy |
|
|||||
2017
Q2 | $140M | Buy |
|
|||||
2017
Q1 | $127M | Buy |
|
|||||
2016
Q4 | $75.7M | Sell |
|
|||||
2016
Q3 | $111M | Buy |
|
|||||
2016
Q2 | $64.5M | Buy |
|
|||||
2016
Q1 | $52.2M | Sell |
|
|||||
2015
Q4 | $68.2M | Buy |
|
|||||
2015
Q3 | $59.4M | Buy |
|
|||||
2015
Q2 | $49.9M | Buy |
|
|||||
2015
Q1 | $39.8M | Buy |
|
|||||
2014
Q4 | $40.6M | Buy |
|
|||||
2014
Q3 | $40.1M | Sell |
|
|||||
2014
Q2 | $43.4M | Sell |
|
|||||
2014
Q1 | $90.2M | Sell |
|
|||||
2013
Q4 | $89.5M | Sell |
|
|||||
2013
Q3 | $80.6M | Buy |
|
|||||
2013
Q2 | $71.8M | Buy |
|